| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease
|
Karnsakul, Wikrom
|
|
|
19 |
4 |
p. 546-552
|
artikel
|
| 2 |
Can exercise replace airway clearance techniques in cystic fibrosis? A survey of patients and healthcare professionals
|
Rowbotham, N.J.
|
|
|
19 |
4 |
p. e19-e24
|
artikel
|
| 3 |
Can lumacaftor-ivacaftor reverse glucose-tolerance abnormalities in cystic fibrosis?
|
Kessler, Laurence
|
|
|
19 |
4 |
p. 666
|
artikel
|
| 4 |
Clinical effect of lumacaftor/ivacaftor in F508del homozygous CF patients with FEV1 ≥ 90% predicted at baseline
|
Aalbers, B.L.
|
|
|
19 |
4 |
p. 654-658
|
artikel
|
| 5 |
Corrigendum to “A single application of the epithelial sodium channel inhibitor BI 1265162 significantly improves water transport and mucociliary clearance of cystic fibrosis epithelial tissue, alone or combined with lumacaftor/ivacaftor or isoproterenol” Journal of Cystic Fibrosis 18 S1 (2019) S41/ePS1.07
|
Nickolaus, P.
|
|
|
19 |
4 |
p. 667
|
artikel
|
| 6 |
Cystic fibrosis in black African children in South Africa: a case control study
|
Owusu, Sandra Kwarteng
|
|
|
19 |
4 |
p. 540-545
|
artikel
|
| 7 |
Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment
|
Kristensen, Maartje
|
|
|
19 |
4 |
p. 553-561
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
19 |
4 |
p. ii
|
artikel
|
| 9 |
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: The international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF)
|
Konstan, M.W.
|
|
|
19 |
4 |
p. 595-601
|
artikel
|
| 10 |
Finding the relevance of antimicrobial stewardship for cystic fibrosis
|
Cogen, Jonathan D.
|
|
|
19 |
4 |
p. 511-520
|
artikel
|
| 11 |
Forskolin-induced swelling of intestinal organoids correlates with disease severity in adults with cystic fibrosis and homozygous F508del mutations
|
de Winter – de Groot, Karin M.
|
|
|
19 |
4 |
p. 614-619
|
artikel
|
| 12 |
Have courage in using nasal potential difference for diagnostic decisions and clinical research
|
Naehrlich, Lutz
|
|
|
19 |
4 |
p. 507-508
|
artikel
|
| 13 |
Identification of Mycobacterium porcinum in patients with cystic Fibrosis: Pathogen or contaminant?
|
Paul, Grace R.
|
|
|
19 |
4 |
p. 580-586
|
artikel
|
| 14 |
Insights into the variability of nasal potential difference, a biomarker of CFTR activity
|
Kyrilli, Spyridoula
|
|
|
19 |
4 |
p. 620-626
|
artikel
|
| 15 |
Integrating the multiple breath washout test into international multicentre trials
|
Saunders, Clare
|
|
|
19 |
4 |
p. 602-607
|
artikel
|
| 16 |
Intraoperative extracorporeal membrane oxygenation for lung transplantation in cystic fibrosis patients: Predictors and impact on outcome
|
Scaravilli, Vittorio
|
|
|
19 |
4 |
p. 659-665
|
artikel
|
| 17 |
JCF Year in Review
|
Flume, Patrick
|
|
|
19 |
4 |
p. 505-506
|
artikel
|
| 18 |
Longitudinal changes in lung function following initiation of lumacaftor/ivacaftor combination
|
Loukou, Ioanna
|
|
|
19 |
4 |
p. 534-539
|
artikel
|
| 19 |
Lymphocyte responses to Mycobacterium tuberculosis and Mycobacterium bovis are similar between BCG-vaccinated patients with cystic fibrosis and healthy controls
|
Mauch, Renan M.
|
|
|
19 |
4 |
p. 575-579
|
artikel
|
| 20 |
Nasal potential difference in suspected cystic fibrosis patients with 5T polymorphism
|
Aalbers, Bente L.
|
|
|
19 |
4 |
p. 627-631
|
artikel
|
| 21 |
News Article
|
|
|
|
19 |
4 |
p. 509-510
|
artikel
|
| 22 |
Outcomes of pregnancy in women with cystic fibrosis (CF) taking CFTR modulators – an international survey
|
Nash, Edward F
|
|
|
19 |
4 |
p. 521-526
|
artikel
|
| 23 |
Pseudomonas aeruginosa antibody response in cystic fibrosis decreases rapidly following lung transplantation
|
Schwensen, Hanna Ferløv
|
|
|
19 |
4 |
p. 587-594
|
artikel
|
| 24 |
Rapid lung function decline in adults with early-stage cystic fibrosis lung disease
|
Dasenbrook, Elliott C.
|
|
|
19 |
4 |
p. 527-533
|
artikel
|
| 25 |
Screening practices for nontuberculous mycobacteria at US cystic fibrosis centers
|
Low, Derek
|
|
|
19 |
4 |
p. 569-574
|
artikel
|
| 26 |
Sputum trypsin-like protease activity relates to clinical outcome in cystic fibrosis
|
Reihill, James
|
|
|
19 |
4 |
p. 647-653
|
artikel
|
| 27 |
Streptococcus pseudopneumoniae, an opportunistic pathogen in patients with cystic fibrosis
|
Dupont, Chloé
|
|
|
19 |
4 |
p. e28-e31
|
artikel
|
| 28 |
Strong toll-like receptor responses in cystic fibrosis patients are associated with higher lung function
|
Kosamo, Susanna
|
|
|
19 |
4 |
p. 608-613
|
artikel
|
| 29 |
The impact of chest computed tomography and chest radiography on clinical management of cystic fibrosis lung disease
|
Bortoluzzi, Carla F.
|
|
|
19 |
4 |
p. 641-646
|
artikel
|
| 30 |
Unmasking catamenial hemoptysis in the era of CFTR modulator therapy
|
Montemayor, Kristina
|
|
|
19 |
4 |
p. e25-e27
|
artikel
|
| 31 |
Use of a mobile application for self-management of pancreatic enzyme replacement therapy is associated with improved gastro-intestinal related quality of life in children with Cystic Fibrosis
|
Boon, M.
|
|
|
19 |
4 |
p. 562-568
|
artikel
|
| 32 |
Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity
|
Sagel, Scott D.
|
|
|
19 |
4 |
p. 632-640
|
artikel
|
Tijdschrift beschrijving